Summit Global Investments’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Sell
6,001
-5,690
-49% -$222K 0.02% 439
2026
Q1
$413K Sell
11,691
-17,971
-61% -$557K 0.02% 364
2025
Q4
$830K Buy
29,662
+9,724
+49% +$291K 0.05% 233
2025
Q3
$598K Buy
+19,938
New +$562K 0.03% 270
2024
Q3
Sell
-46,808
Closed -$1.13M 498
2024
Q2
$1.13M Buy
46,808
+6,913
+17% +$170K 0.08% 221
2024
Q1
$1.08M Buy
+39,895
New +$1.13M 0.08% 196

Other funds holding ALKS

Summit Global Investments's ALKS Position: Q2 2026 in Review

Summit Global Investments reduced its Alkermes (ALKS) stake by 49% in Q2 2026, selling an estimated $222K and leaving 6,001 shares worth $314K. The position accounts for 0.02% of the portfolio, ranked #439.

Summit Global Investments first reported a position in ALKS in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.13M in Q2 2024. 110 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Summit Global Investments held 6,001 shares of Alkermes worth $314K as of Q2 2026.
  • Summit Global Investments sold 5,690 Alkermes shares in Q2 2026, an estimated $222K.
  • Alkermes made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #439 holding.
  • Summit Global Investments first reported a position in Alkermes in Q1 2024 and has held it in 6 quarters since.
  • Summit Global Investments's Alkermes position peaked at $1.13M in Q2 2024.
  • 110 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.